The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Ratain, Mark J.
One or more keywords matched the following items that are connected to Ratain, Mark J.
Item TypeName
Concept Clinical Trials, Phase II as Topic
Academic Article Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents.
Academic Article Promising new agents in oncologic treatment.
Academic Article Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.
Academic Article Rationale for phase I study of UFT plus leucovorin and oral JM-216.
Academic Article Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?
Academic Article Troxacitabine in patients with refractory leukemia.
Academic Article Phase II oncology trials: let's be positive.
Academic Article Randomized phase II trials and prostate-specific antigen endpoints in prostate cancer: much ado about nothing?
Academic Article Clarification regarding "phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties" and the accompanying commentary, "phase II cancer trials: out of control?".
Academic Article Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties.
Academic Article Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Academic Article The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committee.
Academic Article Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.
Academic Article Other paradigms: better treatments are identified by better trials: the value of randomized phase II studies.
Academic Article Evaluating the activity of temsirolimus in neuroendocrine cancer.
Academic Article Optimising the design of phase II oncology trials: the importance of randomisation.
Academic Article Resampling phase III data to assess phase II trial designs and endpoints.
Academic Article Randomized phase II trials: a long-term investment with promising returns.
Academic Article Analysis of the yield of phase II combination therapy trials in medical oncology.
Academic Article Might cigarettes be a "smoking gun" to reduce taxane myelotoxicity?
Academic Article Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Academic Article Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee.
Academic Article Targeted therapies: redefining the primary objective of phase I oncology trials.
Academic Article Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.
Search Criteria
  • Clinical Trials Phase II as Topic